Skip to content

ICU Medical 20116-01Recalls & reported problems

Icu Medical, Inc. · ChemoClave™ Vented Bag Spike · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00840619023256), received between Sep 3, 2024 and Sep 3, 2024 — classified as 1 malfunction.

The most frequently reported specific device problem is “No Flow” (1 report).

7 other recalls cover devices cleared under the same FDA submission (K081361); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 1 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • No Flow1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 3, 2024No Flow; No Flow

    THE EVENT OCCURRED ON AN UNSPECIFIED DATE AND INVOLVED A CHEMOSAFELOCK BAG SPIKE WHERE IT WAS REPORTED THERE WAS AN OCCLUSION. IT WAS STATED THERE ARE 9 INVOLVED PROBLEMATIC DEVICES. THERE WAS UNKNOWN PATIENT INVOLVEMENT AND UNKNOWN PATIENT HARM. THIS REPORT CAPTURES 9 OCCURRENCES.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20127783 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K081361. One submission often covers many models, so check the product and lot details in each record.

  • Z-3158-2026 · May 12, 2026 · Open, Classified
    Oncology sets with drip chambers
  • Z-3160-2026 · May 12, 2026 · Open, Classified
    IV Sets with drip chambers
  • Z-1566-2021 · Mar 16, 2021 · Open, Classified
    REF CH3582 5 IN (13cm) APPX 0.57 ml, EXT SET, ANTI-SHIPHON VALVE, Spiros LOT 5125197 - Product Usage: for use in the preparation and patient administration of cytotoxic medications
  • Z-1565-2021 · Mar 16, 2021 · Open, Classified
    REF CH3397 Oncology Kit w/Spiros, Red Cap, Bag Spike w/Clave Additive Port LOT 5118610 - Product Usage: for use in the preparation and patient administration of cytotoxic medicatio
  • Z-0701-2021 · Aug 31, 2020 · Open, Classified
    5 IN (13 cm) Appx 1.5 ml, Bag Spike Adapter, Spiros, REF: 20123-01; 75" (191 cm) Appx 9.1 ml, 20 Drop Admin Set w/ Integrated Clave Drip Chamber, Clave, Spiros, REF: CH3035; 40" (1
  • Z-1093-2019 · Feb 21, 2019 · Terminated
    icumedical ChemoClave Vented Vial Spike, 20 mm, REF CH-80S. Used in IV administration sets. The ChemoClave is a needle-free Closed System Transfer Device (CSTD) that mechanical
  • Z-1092-2019 · Feb 21, 2019 · Terminated
    icumedical ChemoClave Vented Vial Spike, 20 mm, REF CH-70S . Used in IV administration sets. The ChemoClave is a needle-free Closed System Transfer Device (CSTD) that mechanica

Other Set, administration, intravascular devices

All Set, administration, intravascular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page